Commentary: Acute and late toxicity in prostate cancer patients treated with moderately vs ultra-hypofractionated radiotherapy - Quiz - MDSpire

Analysis of Acute and Long-Term Toxicity in Prostate Cancer Patients Undergoing Moderately Versus Ultra-Hypofractionated Radiotherapy

  • By

  • Toufic Eid

  • Tarek Al-Bitar

  • Osama Mohamad

  • July 20, 2026

Share

Original Source(s)

Commentary: Acute and late toxicity in prostate cancer patients treated with moderately vs ultra-hypofractionated radiotherapy

  • by Toufic Eid, Tarek Al-Bitar, Osama Mohamad

  • July 20, 2026

Related Content

An FDG-first functional imaging approach in phaeochromocytoma and paraganglioma

Targeting stroma-mediated T-cell exclusion and functional exhaustion in pancreatic ductal adenocarcinoma through CXCR4 and PD-1 blockade

Prognostic analysis of first-recurrence/metastasis esophageal squamous cell carcinoma: chemoimmunotherapy combined with radiotherapy as one of the optimal clinical management strategies